94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
An Erratum on
PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma
By Al-Ghazzawi K, Wessolly M, Dalbah S, Ketteler P, Kiefer T, Bechrakis N, Leyla J, Ting S, Biewald E and Mairinger FD (2023) Front. Oncol. 13:1144951. doi: 10.3389/fonc.2023.1144951
Due to a production error, section 3.2 Anaplastic grade included two empty subsections: 3.2.1 Undifferentiated retinoblastoma and 3.2.2 Differentiated retinoblastoma. These subsections have been removed.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: retinoblastoma - epigenetics, retinoblastoma, PDGF = platelet-derived growth factor, MAPK/ERK2 pathway 1, pediatric cancer and oncology, biomarkers, targeted therapy, growth factors (angiogenesis factors)
Citation: Frontiers Production Office (2023) Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Front. Oncol. 13:1339187. doi: 10.3389/fonc.2023.1339187
Received: 15 November 2023; Accepted: 15 November 2023;
Published: 07 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn